Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecBiohitOrionModulight

Latest content

ShowingAll content types

Faron drew down the second tranche of the convertible bond

Analyst Comment 12.12.2025, 07.43 by Antti Siltanen
Faron Pharmaceuticals

Nightingale's CFO departs suddenly

Analyst Comment 09.12.2025, 06.53 by Antti Luiro, Antti Siltanen
Nightingale Health

New study on the benefits of GastroPanel in guiding treatment

Analyst Comment 09.12.2025, 06.52 by Antti Siltanen
Biohit

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Faron presented updated BEXMAB data at the ASH meeting

Analyst Comment 09.12.2025, 06.50 by Antti Siltanen
Faron Pharmaceuticals

Herantis: Valuation is attractive again

Research 20.11.2025, 11.26 by Antti Siltanen
Herantis Pharma

Bioretec: Building a new beginning

Research 14.11.2025, 12.18 by Antti Siltanen
Bioretec

Biohit: Chilean cancer project raises long-term potential

Research 13.11.2025, 09.45 by Antti Siltanen
Biohit

Nightingale strengthens its research offering through strategic partnership

Analyst Comment 05.11.2025, 15.59 by Antti Luiro, Antti Siltanen
Nightingale Health

Modulight Q3'25: Risks grew more than potential

Research 27.10.2025, 09.34 by Antti Siltanen
Modulight

Faron: The share price drops offers a chance to buy more

Research 24.10.2025, 07.36 by Antti Siltanen
Faron Pharmaceuticals
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.